A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells

Enrolling by invitationOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions

Transverse Myelitis

Interventions

DRUG

Q-Cells®

Long term observational study of patients who received 1 of 3 different amounts of Q-Cells®.

Trial Locations (1)

The University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER